Teva Pharmaceutical Industries Balance Sheet (2009-2026) | TEVJF

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)	2.04B	2.17B	2.17B	2.06B	2.23B	2.80B	2.14B	2.67B	2.25B	3.23B	2.99B	2.26B	3.32B	3.30B	1.70B	2.16B	2.20B	3.56B	3.74B	3.65B
Short-term Investments (Quarter)
Cash & Current Investments (Quarter)	2.04B	2.17B	2.17B	2.06B	2.23B	2.80B	2.14B	2.67B	2.25B	3.23B	2.99B	2.26B	3.32B	3.30B	1.70B	2.16B	2.20B	3.56B	3.74B	3.65B
Receivables - Net (Quarter)	4.05B	4.53B	4.25B	4.47B	3.73B	3.70B	3.44B	3.54B	3.38B	3.41B	3.46B	3.77B	3.46B	3.06B	3.38B	3.56B	3.81B	3.71B	3.39B	3.49B
Receivables (Quarter)	4.05B	4.53B	4.25B	4.47B	3.73B	3.70B	3.44B	3.54B	3.38B	3.41B	3.46B	3.77B	3.46B	3.06B	3.38B	3.56B	3.81B	3.71B	3.39B	3.49B
Raw Materials (Quarter)
Work In Process (Quarter)
Finished Goods (Quarter)
Inventory (Quarter)	4.17B	3.82B	4.01B	4.05B	3.86B	3.83B	4.12B	4.11B	4.05B	4.02B	3.95B	3.93B	3.96B	3.01B	3.25B	3.50B	3.32B	3.18B	3.18B	3.22B
Current Deferred Tax Assets (Quarter)
Prepaid Assets (Quarter)	1.07B	1.07B	1.06B	1.05B	1.04B	1.16B	1.25B	1.23B	1.17B	1.25B	1.34B	1.10B	1.13B	1.01B	1.02B	1.08B	1.11B	1.12B	1.07B	1.03B
Current Assets (Quarter)	12.15B	12.57B	12.45B	12.16B	11.45B	12.05B	11.50B	12.09B	11.43B	12.48B	12.30B	11.63B	12.31B	12.55B	11.53B	12.62B	12.74B	13.95B	13.71B	13.76B
Non-Current Assets
Buildings (Quarter)		2.57B				2.46B				2.49B				1.97B				2.33B
Land & Improvements (Quarter)
Property, Plant & Equipment (Net) (Quarter)	6.04B	5.98B	5.93B	5.74B	5.57B	5.74B	5.75B	5.71B	5.62B	5.75B	5.62B	5.57B	5.67B	4.58B	4.63B	4.81B	4.82B	4.08B	4.00B	3.93B
Long-Term Investments (Quarter)
Goodwill (Quarter)	20.18B	17.63B	19.99B	0.48B	18.43B	17.18B	17.80B	17.12B	16.89B	17.18B	17.01B	16.49B	16.12B	16.00B	15.48B	15.95B	15.95B	16.00B	15.82B	15.84B
Intangibles (Quarter)	7.83B	7.47B	7.12B	6.70B	6.39B	6.27B	5.96B	5.74B	5.53B	5.39B	5.06B	4.85B	4.76B	4.42B	4.19B	4.14B	3.94B	3.78B	3.61B	3.45B
Goodwill & Intangibles (Quarter)	28.01B	25.10B	27.10B	7.18B	24.83B	23.45B	23.76B	22.86B	22.41B	22.56B	22.06B	21.34B	20.88B	20.42B	19.67B	20.09B	19.88B	19.78B	19.43B	19.29B
Long-Term Deferred Tax (Quarter)	0.62B	0.60B	0.64B	1.59B	1.55B	1.46B	1.58B	1.58B	1.75B	1.81B	1.96B	2.00B	2.07B	1.80B	1.76B	1.78B	1.63B	2.19B	2.19B	2.16B
Other Non-Current Assets (Quarter)	0.52B	0.52B	0.47B	0.45B	0.44B	0.44B	0.45B	0.44B	0.48B	0.47B	0.47B	0.43B	0.46B	1.77B	1.81B	1.84B	1.81B	1.84B	1.79B	1.79B
Non-Current Assets (Quarter)	35.70B	35.09B	34.61B	33.77B	32.80B	31.96B	31.96B	31.01B	30.67B	30.99B	30.48B	29.71B	29.44B	26.77B	26.89B	27.51B	27.12B	26.80B	26.33B	26.10B
Assets (Quarter)	47.85B	47.67B	47.06B	45.93B	44.25B	44.01B	43.46B	43.10B	42.09B	43.48B	42.77B	41.34B	41.76B	39.33B	38.41B	40.13B	39.86B	40.75B	40.04B	39.86B
Liabilities
Current Liabilities
Accounts Payables (Quarter)	1.51B	1.69B	1.75B	1.90B	1.64B	1.89B	2.38B	2.51B	2.28B	2.60B	2.44B	2.37B	2.37B	2.20B	2.29B	2.50B	2.35B	2.53B	2.60B	2.72B
Notes Payables (Quarter)
Payables (Quarter)	1.51B	1.69B	1.75B	1.90B	1.64B	1.89B	2.38B	2.51B	2.28B	2.60B	2.44B	2.37B	2.37B	2.20B	2.29B	2.50B	2.35B	2.53B	2.60B	2.72B
Accumulated Expenses (Quarter)	2.04B	2.21B	2.60B	2.11B	2.04B	2.15B	2.27B	2.50B	2.74B	2.77B	2.78B	2.84B	2.98B	2.79B	2.95B	3.10B	2.99B	2.69B	2.62B	2.74B
Other Accumulated Expenses (Quarter)	0.77B	0.90B	0.90B	0.92B	0.94B	1.00B	1.00B	0.97B	1.01B	1.04B	1.16B	1.19B	1.24B	1.02B	0.96B	0.94B	1.10B	1.18B	1.11B	0.99B
Short term Debt (Quarter)	2.71B	1.43B	2.08B	1.72B	2.77B	2.11B	1.02B	1.98B	1.48B	1.67B	3.06B	2.09B	2.58B	1.78B	0.42B	0.46B	0.02B	1.82B	2.61B	4.50B
Total Current Liabilities (Quarter)	11.82B	11.03B	11.61B	11.00B	11.53B	11.47B	10.41B	11.84B	11.39B	12.25B	13.79B	13.04B	13.80B	12.80B	11.16B	11.86B	11.49B	13.46B	13.53B	15.65B
Non-Current Liabilities
Non-Current Debt (Quarter)	21.04B	21.62B	20.84B	20.36B	18.50B	19.10B	19.67B	18.70B	18.50B	18.16B	16.58B	16.55B	16.40B	16.00B	16.23B	16.76B	16.77B	14.99B	14.02B	12.09B
Convertible Debt (Quarter)
Pension (Quarter)
Minority Interest (Quarter)	0.98B	0.97B	0.92B	0.79B	0.75B	0.79B	0.75B	0.66B	0.58B	0.62B	0.27B	0.20B	0.32B	0.34B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B
Liabilities from Discontinued Operations (Quarter)
Non-Current Deferred Tax Liability (Quarter)	0.91B	0.78B	0.67B	0.53B	0.50B	0.55B	0.55B	0.53B	0.54B	0.61B	0.57B	0.55B	0.54B	0.48B	0.46B	0.44B	0.40B	0.30B	0.27B	0.29B
Operating Leases (Quarter)	0.42B	0.53B	0.39B	0.37B	0.35B	0.44B	0.34B	0.34B	0.32B	0.42B	0.29B	0.28B	0.29B	0.38B	0.29B	0.30B	0.28B	0.29B	0.28B	0.28B
Other Non-Current Liabilities (Quarter)	2.20B	2.58B	3.29B	3.86B	3.86B	3.94B	3.98B	4.09B	3.95B	4.02B	3.99B	4.36B	4.34B	4.03B	4.01B	3.94B	3.66B	3.81B	3.71B	3.79B
Total Non-Current Liabilities (Quarter)	24.57B	25.39B	25.19B	25.12B	23.21B	23.94B	24.55B	23.66B	23.31B	23.11B	21.44B	21.74B	21.58B	20.81B	20.99B	21.44B	21.11B	19.38B	18.28B	16.45B
Total Liabilities (Quarter)	36.40B	36.42B	36.80B	36.12B	34.75B	35.41B	34.96B	35.51B	34.71B	35.35B	35.23B	34.77B	35.38B	33.61B	32.15B	33.30B	32.60B	32.83B	31.81B	32.10B
Shareholder's Equity
Total Debt (Quarter)	23.75B	23.04B	22.92B	22.08B	21.27B	21.21B	20.69B	20.68B	19.97B	19.83B	19.64B	18.64B	18.98B	17.78B	16.65B	17.23B	16.79B	16.81B	16.63B	16.59B
Common Equity (Quarter)	11.45B	11.24B	10.26B	9.81B	9.51B	8.60B	8.50B	7.59B	7.39B	8.13B	7.54B	6.56B	6.38B	5.38B	6.27B	6.83B	7.25B	7.91B	8.23B	7.76B
Liabilities and Shareholders Equity (Quarter)	47.85B	47.67B	47.06B	45.93B	44.25B	44.01B	43.46B	43.10B	42.09B	43.48B	42.77B	41.34B	41.76B	39.33B	38.41B	40.13B	39.86B	40.75B	40.04B	39.86B
Treasury Shares (Quarter)	0.11B	0.02B	0.11B	0.11B	0.11B	0.03B	0.11B	0.11B	0.11B	0.04B	0.11B	0.11B	0.11B	0.11B	0.11B	0.11B	0.11B	0.11B	0.11B	0.11B
Retained Earnings (Quarter)	-2.62B	-2.68B	-2.69B	-11.73B	-11.67B	-2.84B	-2.70B	-14.07B	-13.99B	-2.70B	-2.77B	27.83B	27.86B	27.76B	27.96B	28.00B	28.04B	28.13B	28.20B	28.26B
Preferred Shares (Quarter)

Research Tools

Datasets

Plans

Developers

Teva Pharmaceutical Industries Balance Sheet (2009-2026) | TEVJF

Research Tools

Datasets

Plans

Developers

Teva Pharmaceutical Industries Balance Sheet (2009-2026) | TEVJF

Create an account

Sign In

Reset Password